Alizé Pharma 3, a company specialized in developing therapeutic peptides for the treatment of rare endocrine and metabolic diseases, today announces a key addition to its leadership team and the structuring of its product portfolio in line with its ambition to become a  leading global rare disease company.

Complete press release Alize Pharma 3